Why the study?
Does transdermal nitroglycerin improve exercise duration in patients with stable, exercise-induced angina?
Does transdermal nitroglycerin improve exercise duration in patients with stable, exercise-induced angina?
Answers are grounded in this paper and cite their sources.
Transdermal nitroglycerin significantly improves exercise duration in patients with stable angina without acute tolerance up to 24 hours.
Letters and Corrections1 February 1987Transdermal Nitroglycerin and Nitrate ToleranceAUDREY G. KRIEGMAN, M.D.AUDREY G. KRIEGMAN, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-106-2-325 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: In his editorial in the March 1986 issue, Dr. Abrams (1) failed to mention the results of several recent acute and chronic dose studies that showed lack of tolerance to transdermal nitroglycerin.In a double-blind study Scardi and colleagues (2) evaluated the acute effects of two doses of Transderm-Nitro (nitroglycerin; Ciba Pharmaceutical Co., Summit, New Jersey) at 4 and 24 hours after patch application in 15 patients with stable, exercise-induced angina. In comparison with placebo, both doses of Transderm-Nitro (10 and 20 mg/24 h) produced a statistically significant increase (p< 0.01) in exercise duration to 1-mm...References1. ABRAMS J. Transdermal nitroglycerin and nitrate tolerance [Editorial]. Ann Intern Med. 1986;104:424-6. LinkGoogle Scholar2. SCARDIPIVOTTIFONDA SFF. Effect of a new transdermal therapeutic system containing nitroglycerin on exercise capacity in patients with angina pectoris. Am Heart J 1985;110:546-51. CrossrefMedlineGoogle Scholar3. SELLIERAUDOUINPAYEN PPB. Therapeutic efficacy of transcutaneously absorbed nitroglycerin evaluated by exercise testing in angina patients. Cardiovasc Rev Rep. 1985;6:84-8. Google Scholar4. MUIESANAGABITI-ROSEIMUIESAN GEL. A multicenter trial of transdermal nitroglycerin in exercise-induced angina: individual antianginal response after repeated administration. Am Heart J. 1986;112:233-8. CrossrefMedlineGoogle Scholar5. MARTINES C. Comparison of the prophylactic antianginal effect of two doses of Nitroderm TTS in out-patients with stable angina pectoris. Curr Ther Res. 1984;36:483-9. Google Scholar1. ABRAMS J. The brief saga of transdermal nitroglycerin discs: paradise lost? Am J Cardiol. 1985;54:220-4. CrossrefGoogle Scholar2. ABRAMS J. Transdermal nitroglycerin: ointment or disc [Editorial]? Am Heart J 1984;108:1597-600. CrossrefMedlineGoogle Scholar3. BUSSMANZANCHETTI WA eds. Transdermal Nitroglycerin Therapy. Berne: Hans Huber Publishers; 1985:1-70. Google Scholar4. PARKER J. N Engl J Med. (In press). Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: AUDREY G. KRIEGMAN, M.D.Affiliations: Ciba-Geigy Corporation Summit, NJ 07901 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 February 1987Volume 106, Issue 2Page: 325-326KeywordsAnginaExerciseNitrates ePublished: 1 December 2008 Issue Published: 1 February 1987 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Audrey Kriegman (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: